Skip to main content

Find Clinical Trials

Home
Conditions
Respiratory Tract Neoplasms

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,109 public trials 1,857 recruiting studies

Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Not Yet Recruiting

SERS-Based Serum Molecular Spectral Screening for Lung Cancer Type

NCT06775002

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

SERS-Based Serum Molecular Spectral Screening for Hematogenous Metastasis

NCT06772363

Conditions: Lung Cancers, Lung Diseases, Lung Neoplasms, +5 more
Locations: Raman detector Fuzhou, Fujian, China

View Trial Details

Not Yet Recruiting

Firmonertinib Combined With Chemotherapy as Neoadjuvant Therapy for Resectable Stage Ⅱ-ⅢB EGFR Sensitive Mutanted NSCLC

NCT06890182

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Study of MCLA-129 in the Treatment of Advanced Non-small Cell Lung Cancer with AGA and MET Amplification.

NCT06885840

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China

The First Hospital of Lanzhou University Lanzhou, Gansu, China

Dongguan People's Hospital Dongguan, Guangdong, China

Foshan First People's Hospital Foshan, Guangdong, China

View all 20 locations

View Trial Details

Not Yet Recruiting

An Open-label, Single-arm Clinical Study of Stapokibart Injection in Combination with Tislelizumab Injection in Patients with Non-Small Cell Lung Cancer

NCT06883552

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Phase I/ II Study of Fragmented Autoantigen Stimulated T-cell-immunotherapy Combined with Radiotherapy (FAST-CR)

NCT06756295

Conditions: Breast Cancer, Colorectal Cancer, Breast Diseases, Breast Neoplasms, +27 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Lorlatinib Compared with Concurrent/ Sequential Chemoradiotherapy in Stage III ALK Positive Lung Adenocarcinoma

NCT06858410

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Construction of a Prognostic and Prediction Model for Perioperative Immunotherapy in NSCLC: A Multi - Omics Perspective

NCT06856798

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Prospective Study Investigating the Relationship Between Minimal Residual Disease Detection, Monitoring Frequency, and Prognosis in Non-small Cell Lung Cancer Patients Eligible for Curative Treatment.

NCT06854939

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations: National Cancer Center Hospital Chuo-ku, Tokyo, Japan

View Trial Details

Not Yet Recruiting

This is a Two-cohort, Exploratory Clinical Study Assessing the Activity of Benmelstobart Alone or Combined with Anlotinib Administered Prior to Surgery in Terms of Pathological Complete Response

NCT06851169

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details